Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-10

Clinical Trial Update: A Pilot Study in Severe Patients With Takayasu Arteritis. [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial update investigating biological therapy for Takayasu Arteritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)
  • Tocilizumab (tocilizumab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Takayasu Arteritis, Tocilizumab | Phase 4 | Status: RECRUITING